Global Cell and Gene Therapy Manufacturing QC Market Growth (Status and Outlook) 2021-2026

Publication Month: May 2021 | No. of Pages: 116 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this latest study, the 2021 growth of Cell and Gene Therapy Manufacturing QC will have significant change from previous year. By the most conservative estimates of global Cell and Gene Therapy Manufacturing QC market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Cell and Gene Therapy Manufacturing QC market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Manufacturing QC market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Safety Testing
Purity Testing
Potency Testing
Identity Testing
Stability Testing

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Precision Therapy
Biological Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bio-Techne Corporation
BioMerieux SA
Catalent, Inc.
Charles River Laboratories International Inc.
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Intertek Group plc
Lonza Group AG
Merck KGaA
Sartorius AG
SGS S.A.
Sistemic Scotland Limited
Thermo Fisher Scientific Inc.
Vigene Biosciences, Inc.
WuXi AppTec

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing QC Market Size 2016-2026
2.1.2 Cell and Gene Therapy Manufacturing QC Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Cell and Gene Therapy Manufacturing QC Segment by Type
2.2.1 Safety Testing
2.2.2 Safety Testing
2.2.3 Potency Testing
2.2.4 Identity Testing
2.2.5 Stability Testing
2.3 Cell and Gene Therapy Manufacturing QC Market Size by Type
2.3.1 Global Cell and Gene Therapy Manufacturing QC Market Size CAGR by Type
2.3.2 Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2016-2021)
2.4 Cell and Gene Therapy Manufacturing QC Segment by Application
2.4.1 Precision Therapy
2.4.2 Biological Research
2.5 Cell and Gene Therapy Manufacturing QC Market Size by Application
2.5.1 Global Cell and Gene Therapy Manufacturing QC Market Size CAGR by Application
2.5.2 Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2016-2021)

3 Cell and Gene Therapy Manufacturing QC Market Size by Players
3.1 Cell and Gene Therapy Manufacturing QC Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2019-2021E)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2019-2021E)
3.2 Global Cell and Gene Therapy Manufacturing QC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy Manufacturing QC by Regions
4.1 Cell and Gene Therapy Manufacturing QC Market Size by Regions (2016-2021)
4.2 Americas Cell and Gene Therapy Manufacturing QC Market Size Growth (2016-2021)
4.3 APAC Cell and Gene Therapy Manufacturing QC Market Size Growth (2016-2021)
4.4 Europe Cell and Gene Therapy Manufacturing QC Market Size Growth (2016-2021)
4.5 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Growth (2016-2021)

5 Americas
5.1 Americas Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021)
5.2 Americas Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
5.3 Americas Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021)
6.2 APAC Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
6.3 APAC Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing QC by Country (2016-2021)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC by Region (2016-2021)
8.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021)
8.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Cell and Gene Therapy Manufacturing QC Market Forecast
10.1 Global Cell and Gene Therapy Manufacturing QC Forecast by Regions (2021-2026)
10.1.1 Global Cell and Gene Therapy Manufacturing QC Forecast by Regions (2021-2026)
10.1.2 Americas Cell and Gene Therapy Manufacturing QC Forecast
10.1.3 APAC Cell and Gene Therapy Manufacturing QC Forecast
10.1.4 Europe Cell and Gene Therapy Manufacturing QC Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing QC Forecast
10.2 Americas Cell and Gene Therapy Manufacturing QC Forecast by Countries (2021-2026)
10.2.1 United States Cell and Gene Therapy Manufacturing QC Market Forecast
10.2.2 Canada Cell and Gene Therapy Manufacturing QC Market Forecast
10.2.3 Mexico Cell and Gene Therapy Manufacturing QC Market Forecast
10.2.4 Brazil Cell and Gene Therapy Manufacturing QC Market Forecast
10.3 APAC Cell and Gene Therapy Manufacturing QC Forecast by Region (2021-2026)
10.3.1 China Cell and Gene Therapy Manufacturing QC Market Forecast
10.3.2 Japan Cell and Gene Therapy Manufacturing QC Market Forecast
10.3.3 Korea Cell and Gene Therapy Manufacturing QC Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Forecast
10.3.5 India Cell and Gene Therapy Manufacturing QC Market Forecast
10.3.6 Australia Cell and Gene Therapy Manufacturing QC Market Forecast
10.4 Europe Cell and Gene Therapy Manufacturing QC Forecast by Country (2021-2026)
10.4.1 Germany Cell and Gene Therapy Manufacturing QC Market Forecast
10.4.2 France Cell and Gene Therapy Manufacturing QC Market Forecast
10.4.3 UK Cell and Gene Therapy Manufacturing QC Market Forecast
10.4.4 Italy Cell and Gene Therapy Manufacturing QC Market Forecast
10.4.5 Russia Cell and Gene Therapy Manufacturing QC Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Manufacturing QC Forecast by Region (2021-2026)
10.5.1 Egypt Cell and Gene Therapy Manufacturing QC Market Forecast
10.5.2 South Africa Cell and Gene Therapy Manufacturing QC Market Forecast
10.5.3 Israel Cell and Gene Therapy Manufacturing QC Market Forecast
10.5.4 Turkey Cell and Gene Therapy Manufacturing QC Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Manufacturing QC Market Forecast
10.6 Global Cell and Gene Therapy Manufacturing QC Forecast by Type (2021-2026)
10.7 Global Cell and Gene Therapy Manufacturing QC Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Information
11.1.2 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product Offered
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Bio-Techne Corporation Main Business Overview
11.1.5 Bio-Techne Corporation Latest Developments
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Information
11.2.2 BioMerieux SA Cell and Gene Therapy Manufacturing QC Product Offered
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 BioMerieux SA Main Business Overview
11.2.5 BioMerieux SA Latest Developments
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Information
11.3.2 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product Offered
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Catalent, Inc. Main Business Overview
11.3.5 Catalent, Inc. Latest Developments
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Information
11.4.2 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product Offered
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Charles River Laboratories International Inc. Main Business Overview
11.4.5 Charles River Laboratories International Inc. Latest Developments
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Information
11.5.2 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product Offered
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Eurofins Scientific SE Main Business Overview
11.5.5 Eurofins Scientific SE Latest Developments
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Information
11.6.2 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product Offered
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.6.5 F. Hoffmann-La Roche Ltd Latest Developments
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Information
11.7.2 Intertek Group plc Cell and Gene Therapy Manufacturing QC Product Offered
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Intertek Group plc Main Business Overview
11.7.5 Intertek Group plc Latest Developments
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Information
11.8.2 Lonza Group AG Cell and Gene Therapy Manufacturing QC Product Offered
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Lonza Group AG Main Business Overview
11.8.5 Lonza Group AG Latest Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Cell and Gene Therapy Manufacturing QC Product Offered
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Merck KGaA Main Business Overview
11.9.5 Merck KGaA Latest Developments
11.10 Sartorius AG
11.10.1 Sartorius AG Company Information
11.10.2 Sartorius AG Cell and Gene Therapy Manufacturing QC Product Offered
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Sartorius AG Main Business Overview
11.10.5 Sartorius AG Latest Developments
11. SGS S.A.
11.11.1 SGS S.A. Company Information
11.11.2 SGS S.A. Cell and Gene Therapy Manufacturing QC Product Offered
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 SGS S.A. Main Business Overview
11.11.5 SGS S.A. Latest Developments
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Information
11.12.2 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product Offered
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Sistemic Scotland Limited Main Business Overview
11.12.5 Sistemic Scotland Limited Latest Developments
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Information
11.13.2 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product Offered
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Thermo Fisher Scientific Inc. Main Business Overview
11.13.5 Thermo Fisher Scientific Inc. Latest Developments
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Information
11.14.2 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product Offered
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Vigene Biosciences, Inc. Main Business Overview
11.14.5 Vigene Biosciences, Inc. Latest Developments
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Information
11.15.2 WuXi AppTec Cell and Gene Therapy Manufacturing QC Product Offered
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 WuXi AppTec Main Business Overview
11.15.5 WuXi AppTec Latest Developments

12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Cell and Gene Therapy Manufacturing QC Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Safety Testing
Table 3. Major Players of Purity Testing
Table 4. Major Players of Potency Testing
Table 5. Major Players of Identity Testing
Table 6. Major Players of Stability Testing
Table 7. Cell and Gene Therapy Manufacturing QC Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2016-2021)
Table 10. Cell and Gene Therapy Manufacturing QC Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2016-2021)
Table 13. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2019-2021E)
Table 15. Cell and Gene Therapy Manufacturing QC Key Players Head office and Products Offered
Table 16. Cell and Gene Therapy Manufacturing QC Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Cell and Gene Therapy Manufacturing QC Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Regions 2016-2021
Table 21. Americas Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country (2016-2021)
Table 23. Americas Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2016-2021)
Table 25. Americas Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2016-2021)
Table 27. APAC Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region (2016-2021)
Table 29. APAC Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2016-2021)
Table 31. APAC Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2016-2021)
Table 33. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country (2016-2021)
Table 35. Europe Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2016-2021)
Table 37. Europe Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Cell and Gene Therapy Manufacturing QC
Table 46. Key Application and Potential Industries of Cell and Gene Therapy Manufacturing QC
Table 47. Key Challenges of Cell and Gene Therapy Manufacturing QC
Table 48. Key Trends of Cell and Gene Therapy Manufacturing QC
Table 49. Global Cell and Gene Therapy Manufacturing QC Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share Forecast by Regions (2021-2026)
Table 51. Global Cell and Gene Therapy Manufacturing QC Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Cell and Gene Therapy Manufacturing QC Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share Forecast by Application (2021-2026)
Table 55. Bio-Techne Corporation Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 56. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product Offered
Table 57. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. Bio-Techne Corporation Main Business
Table 59. Bio-Techne Corporation Latest Developments
Table 60. BioMerieux SA Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 61. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product Offered
Table 62. BioMerieux SA Main Business
Table 63. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. BioMerieux SA Latest Developments
Table 65. Catalent, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 66. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product Offered
Table 67. Catalent, Inc. Main Business
Table 68. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. Catalent, Inc. Latest Developments
Table 70. Charles River Laboratories International Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 71. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product Offered
Table 72. Charles River Laboratories International Inc. Main Business
Table 73. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Charles River Laboratories International Inc. Latest Developments
Table 75. Eurofins Scientific SE Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 76. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product Offered
Table 77. Eurofins Scientific SE Main Business
Table 78. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. Eurofins Scientific SE Latest Developments
Table 80. F. Hoffmann-La Roche Ltd Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 81. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product Offered
Table 82. F. Hoffmann-La Roche Ltd Main Business
Table 83. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. F. Hoffmann-La Roche Ltd Latest Developments
Table 85. Intertek Group plc Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 86. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product Offered
Table 87. Intertek Group plc Main Business
Table 88. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. Intertek Group plc Latest Developments
Table 90. Lonza Group AG Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 91. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product Offered
Table 92. Lonza Group AG Main Business
Table 93. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Lonza Group AG Latest Developments
Table 95. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 96. Merck KGaA Cell and Gene Therapy Manufacturing QC Product Offered
Table 97. Merck KGaA Main Business
Table 98. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. Merck KGaA Latest Developments
Table 100. Sartorius AG Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 101. Sartorius AG Cell and Gene Therapy Manufacturing QC Product Offered
Table 102. Sartorius AG Main Business
Table 103. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. Sartorius AG Latest Developments
Table 105. SGS S.A. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 106. SGS S.A. Cell and Gene Therapy Manufacturing QC Product Offered
Table 107. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 108. SGS S.A. Main Business
Table 109. SGS S.A. Latest Developments
Table 110. Sistemic Scotland Limited Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 111. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product Offered
Table 112. Sistemic Scotland Limited Main Business
Table 113. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 114. Sistemic Scotland Limited Latest Developments
Table 115. Thermo Fisher Scientific Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 116. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product Offered
Table 117. Thermo Fisher Scientific Inc. Main Business
Table 118. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. Thermo Fisher Scientific Inc. Latest Developments
Table 120. Vigene Biosciences, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 121. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product Offered
Table 122. Vigene Biosciences, Inc. Main Business
Table 123. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Vigene Biosciences, Inc. Latest Developments
Table 125. WuXi AppTec Details, Company Type, Cell and Gene Therapy Manufacturing QC Area Served and Its Competitors
Table 126. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product Offered
Table 127. WuXi AppTec Main Business
Table 128. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 129. WuXi AppTec Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2020
Figure 7. Cell and Gene Therapy Manufacturing QC in Precision Therapy
Figure 8. Global Cell and Gene Therapy Manufacturing QC Market: Precision Therapy (2016-2021) & ($ Millions)
Figure 9. Cell and Gene Therapy Manufacturing QC in Biological Research
Figure 10. Global Cell and Gene Therapy Manufacturing QC Market: Biological Research (2016-2021) & ($ Millions)
Figure 11. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2020
Figure 12. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Player in 2020
Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Cell and Gene Therapy Manufacturing QC Market Size 2016-2021 ($ Millions)
Figure 15. APAC Cell and Gene Therapy Manufacturing QC Market Size 2016-2021 ($ Millions)
Figure 16. Europe Cell and Gene Therapy Manufacturing QC Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size 2016-2021 ($ Millions)
Figure 18. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country in 2020
Figure 19. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2020
Figure 20. Americas Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2020
Figure 21. United States Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Regions in 2020
Figure 25. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2020
Figure 26. APAC Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2020
Figure 27. China Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Country in 2020
Figure 34. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2020
Figure 35. Europe Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2020
Figure 36. Germany Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Market Share by Application in 2020
Figure 44. Egypt Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Cell and Gene Therapy Manufacturing QC Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 50. APAC Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 51. Europe Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 53. United States Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 54. Canada Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 57. China Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 58. Japan Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 59. Korea Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 61. India Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 62. Australia Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 63. Germany Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 64. France Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 65. UK Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 66. Italy Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 67. Russia Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 68. Spain Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 71. Israel Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Cell and Gene Therapy Manufacturing QC Market Size 2021-2026 ($ Millions)


Reason to Buy

  • Current and future of Machinery & Equipment Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Machinery & Equipment Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Machinery & Equipment Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Machinery & Equipment Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets